Low-Dose Remifentanil in Preterm Cesarean Section with General Anesthesia: A Randomized Controlled Trial
CONCLUSIONS: The use of a low dose of remifentanil before cord clamping for a Cesarean section appears to be safe both for the mother and the preterm newborn, but it does not improve maternal or neonatal outcomes.CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov: NCT02029898.PMID:37713021 | DOI:10.1007/s40272-023-00591-w
Source: Paediatric Drugs - Category: Pediatrics Authors: Cl ément Chollat Fabien Tourrel Estelle Houivet Romain Gillet Eric Verspyck Maryline Lecointre St éphane Marret Vincent Comp ère Source Type: research
More News: Anesthesia | Anesthesiology | Cesarean Section | Clinical Trials | Men | Pediatrics | Perinatology & Neonatology | Pregnancy | Respiratory Medicine | Women